resveratrol has been researched along with Parkinsonian Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Guo, Y; Ha, Y; Huang, P; Lian, B; Liu, Q; Wang, Y; Xu, X; Zhang, R | 1 |
| Neerati, P; Palle, S | 1 |
| Mishra, AK; Shukla, S; Singh, MP; Tripathi, MK; Ur Rasheed, MS | 1 |
| Duan, YL; Li, GF; Wang, ZH; Zhang, JL; Zhang, QS; Zheng, DL | 1 |
| Ahmad, A; Hoda, MN; Ishrat, T; Islam, F; Javed, H; Khan, A; Khan, MB; Khan, MM; Khuwaja, G; Raza, SS; Vaibhav, K | 1 |
| Bagatini, PB; Bernardino, GC; Coelho, GP; de Oliveira, RM; Paim, MF; Rodrigues, MF; Saur, L; Schirmer, H; Silva, DV; Souto, AA; Vianna, MR; Xavier, LL | 1 |
| Dixit, A; Patel, DK; Prakash, O; Singh, MP; Srivastava, G; Yadav, S | 1 |
1 review(s) available for resveratrol and Parkinsonian Disorders
| Article | Year |
|---|---|
Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value.
Topics: Animals; Humans; Inflammation; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Resveratrol; Stilbenes; Translational Research, Biomedical | 2016 |
6 other study(ies) available for resveratrol and Parkinsonian Disorders
| Article | Year |
|---|---|
Protective effects of resveratrol liposomes on mitochondria in substantia nigra cells of parkinsonized rats.
Topics: Animals; Disease Models, Animal; HSP90 Heat-Shock Proteins; Liposomes; Mitochondria; Parkinsonian Disorders; Rats; Resveratrol; Substantia Nigra | 2021 |
Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Behavior, Animal; Brain; Disease Models, Animal; Male; Mitochondria; Nanoparticles; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats, Wistar; Resveratrol; Rotenone; Stilbenes | 2018 |
MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Neuroblastoma; Neuroprotective Agents; Parkinsonian Disorders; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation | 2015 |
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Disease Models, Animal; Dopamine; Enzymes; Free Radicals; Glutathione; Lipid Peroxidation; Male; Nerve Degeneration; Neurotoxins; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Phospholipases A2; Rats; Rats, Wistar; Resveratrol; Stilbenes; Substantia Nigra; Thiobarbituric Acid Reactive Substances; Treatment Outcome | 2010 |
The role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: a locomotor analysis.
Topics: Animals; Antioxidants; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Disease Models, Animal; Dopamine; Drosophila melanogaster; Nerve Degeneration; Paraquat; Parkinsonian Disorders; Resveratrol; Stilbenes; Substantia Nigra | 2011 |
Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse.
Topics: Animals; Blotting, Western; Chromatography, High Pressure Liquid; Corpus Striatum; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Dopamine; Fungicides, Industrial; Herbicides; Male; Maneb; Mice; Neuroprotective Agents; Paraquat; Parkinsonian Disorders; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2012 |